Transmembrane emp24 domain-containing protein 6 (TMED6)

Transmembrane emp24 domain-containing protein 6 (TMED6) is a type I transmembrane protein in the p24/TMED family, primarily found in membranes of the endoplasmic reticulum, Golgi apparatus, and ER-Golgi intermediate compartment[3][4]. TMED6 plays a role in vesicle-mediated transport and protein trafficking, particularly in endocrine cells such as pancreatic islet α and β cells, where it is implicated in hormone (insulin and glucagon) production, secretion, and maintenance of glucose homeostasis[2][5]. TMED6 shows pancreas-enriched expression, with higher expression in islet α cells compared to β cells[2]. Knockdown experiments indicate its involvement in proper insulin secretion and potential implication in diabetes when dysregulated[2]. The TMED family, to which TMED6 belongs, is also associated with various human pathologies, including cancer, neurodegenerative diseases, and immune responses, though TMED6-specific roles outside pancreatic biology remain less well-defined[3]. **Key points:** - TMED6 is not classically categorized as a "therapeutic target" (receptor, transporter, enzyme) but rather as a trafficking/regulatory protein, though it is of biomedical interest in diabetes and possibly as a biomarker[1][2]. - No drugs directly interact with TMED6, and no mechanisms of action or safety concerns specific to its pharmacological targeting have been reported as of the latest scientific literature. - RNA aptamers recognizing TMED6 have been used to monitor or modulate islet cell transplantation in diabetes models[1].

Other names

Transmembrane p24 trafficking protein 6UNQ9146/PRO34237p24gamma5MGC23911p24 family protein gamma-5PRO34237SPLL9146p24g5